Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Robert John Hoyer

TitleAsst Professor-Clinical
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus

    Collapse Biography 
    Collapse education and training
    Georgetown University, Washington, DCB.S.5/1998Biology
    Georgetown University School of Medicine, Washington, DCM.D.5/2002
    Mayo Graduate School of Medicine, Rochester, MN6/2005Internal Medicine
    Mayo Graduate School of Medicine, Rochester, MN6/2008Hematology/Oncology
    Collapse awards and honors
    1998Cum Laude, Georgetown University
    1998Sigma Xi Scientific Research Society, Georgetown University
    2013 - 2017"Top Doc" (Peer Nominated), Colorado Springs Style Magazine

    Collapse Overview 
    Collapse overview
    I currently serve as director of Memorial Cancer Center and have served as the lead investigator at Memorial for multiple cooperative group studies. In 2017 Memorial accrued 103 patients to clinical trials. Our group sees between 150-200 new patients per month. We have prospective tumor-boards and multidisciplinary clinics to facilitate identification of patients who may be eligible for research studies.

    On October 1, 2012 Memorial Health System became a part of the University of Colorado Health system. In 2013, Memorial Cancer Center became a Lead Academic Participating Site (LAPS) within the National Clinical Trials Network (NCTN). Memorial Hospital has had a strong track record of cooperative group research collaboration and performance which has increased during the last 4 years as an integral part of the University of Colorado LAPS site. We look forward to the continued integration of clinical trials across the entire University of Colorado Health System and University of Colorado Cancer Center.

    I have developed expertise in gastrointestinal, thoracic and neuro-oncology and regularly staff our weekly multidisciplinary clinics. I serve as Medical Director for Oncology Research at Memorial and meet regularly with investigators, the research team and UCHealth research administration.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hoyer RJ, Leung N, Witzig TE, Lacy MQ. Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis. Am J Hematol. 2007 May; 82(5):409-13. PMID: 17326106.
      View in: PubMed
    2. LeMarbre G, Schinstock C, Hoyer R, Krook J, Tefferi A. Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate. Leuk Res. 2007 Mar; 31(3):414-5. PMID: 17010430.
      View in: PubMed
    3. Hoyer RJ, Arora AS, Baron TH. Complications after traction removal of direct percutaneous endoscopic jejunostomy: three case reports. Gastrointest Endosc. 2005 Nov; 62(5):802-5. PMID: 16246705.
      View in: PubMed
    4. Ellis JM, Hoyer RJ, Costello CN, Mshana RN, Quakyi IA, Mshana MN, Diaby B, Traore M, Johnson AH, Hurley CK. HLA-B allele frequencies in Côte d'Ivoire defined by direct DNA sequencing: identification of HLA-B*1405, B*4410, and B*5302. Tissue Antigens. 2001 Apr; 57(4):339-43. PMID: 11380943.
      View in: PubMed
    5. Marshall JL, Hoyer RJ, Toomey MA, Faraguna K, Chang P, Richmond E, Pedicano JE, Gehan E, Peck RA, Arlen P, Tsang KY, Schlom J. Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J Clin Oncol. 2000 Dec 01; 18(23):3964-73. PMID: 11099326.
      View in: PubMed
    6. Lin YS, Hoyer RJ, Tang TF, Ng J, Hartzmann RJ, Hurley CK. Detection of four novel alleles: DRB1*1130, DRB1*13072, DRB1*1315 and DRB1*1331. Tissue Antigens. 2000 Jan; 55(1):92-6. PMID: 10703621.
      View in: PubMed
    7. Hurley CK, Steiner N, Kosman C, Mitton W, Koester R, Bei M, Bush J, McCormack J, Hahn A, Henson V, Hoyer R, Wade JA, Hartzman RJ, Ng J. Novel HLA-A and HLA-B alleles. Tissue Antigens. 1998 Jul; 52(1):84-7. PMID: 9714480.
      View in: PubMed
    8. Hoyer RJ, Bratlie A, Schreuder GM, Hurley CK. Characterization of a novel HLA-B allele, B*0804, in a Norwegian family. Tissue Antigens. 1997 Sep; 50(3):308-10. PMID: 9331954.
      View in: PubMed
    9. Hurley CK, Steiner N, Hoyer RJ, Menchaca E, Mitton W, Simonis T, Hartzman RJ, Johnson AH, Ng J. Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types. Tissue Antigens. 1996 Mar; 47(3):179-87. PMID: 8740766.
      View in: PubMed
    Hoyer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description

    Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)